GlaxoSmithKline PLC Director/PDMR Shareholding

Data : 01/11/2019 @ 18:19
Fonte : UK Regulatory (RNS & others)
Titolo : Glaxosmithkline Plc (GSK)
Quotazione : 1629.8  0.0 (0.00%) @ 01:00
Quotazione Glaxosmithkline Grafico

GlaxoSmithKline PLC Director/PDMR Shareholding

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico

6 Mesi : Da Ago 2019 a Feb 2020

Clicca qui per i Grafici di Glaxosmithkline

TIDMGSK

RNS Number : 0523S

GlaxoSmithKline PLC

01 November 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Ms E Walmsley 
===  ========================  ============================================= 
 b)   Position/status          Chief Executive Officer 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            The exercise of options over 137,040 Ordinary 
       transaction              Shares, granted on 22 July 2010 under the 
                                GlaxoSmithKline 2009 Share Option Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP12.035    137,040 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information   N/A (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================= 
 e)   Date of the transaction  2019-10-31 
===  ========================  ============================================= 
 f)   Place of the             N/A 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  ============================================ 
 b)   Position/status          Chief Executive Officer 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            The sale of 112,945 Ordinary Shares to 
       transaction              cover the tax and cost of exercise of the 
                                options granted on 22 July 2010 under the 
                                GlaxoSmithKline 2009 Share Option Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                  GBP17.7588    112,945 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   N/A (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-10-31 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
      ========================================================================================== 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ================================================== 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ================================================== 
 c)    Initial notification/                  Initial Notification 
        amendment 
====  ======================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================== 
 a)    Description of                          Ordinary shares of 25 pence each ('Ordinary 
        the financial                           Shares') 
        instrument 
                                                ISIN: GB0009252882 
====  ======================================  ================================================== 
 b)    Nature of the                          Transfer of 24,095 Ordinary Shares to 
        transaction                            spouse for nil consideration. 
====  ======================================  ================================================== 
 c)    Price(s) and volume(s)                   Price(s)                 Volume(s) 
====  ======================================   =======================  ====================== 
    GBP0.00                                                              24,095 
   ===================================================================  ====================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================= 
 e)    Date of the transaction                2019-10-31 
====  ======================================  ================================================== 
 f)    Place of the transaction               N/A 
      ======================================  ================================================== 
 
 
       Details of PDMR/person closely associated with them 
        ('PCA') 
      ========================================================================================== 
 a)    Name                                   Mr David Owen 
====  ======================================  ================================================== 
 b)    Position/status                        PCA of Ms E Walmsley (Chief Executive 
                                               Officer) 
====  ======================================  ================================================== 
 c)    Initial notification/                  Initial Notification 
        amendment 
====  ======================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================== 
 a)    Description of                          Ordinary shares of 25 pence each ('Ordinary 
        the financial                           Shares') 
        instrument 
                                                ISIN: GB0009252882 
====  ======================================  ================================================== 
 b)    Nature of the                          Receipt of 24,095 Ordinary Shares from 
        transaction                            spouse for nil consideration. 
====  ======================================  ================================================== 
 c)    Price(s) and volume(s)                   Price(s)                 Volume(s) 
====  ======================================   =======================  ====================== 
    GBP0.00                                                              24,095 
   ===================================================================  ====================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================= 
 e)    Date of the transaction                2019-10-31 
====  ======================================  ================================================== 
 f)    Place of the transaction               N/A 
      ======================================  ================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHDFLFBKFFFFBE

(END) Dow Jones Newswires

November 01, 2019 13:19 ET (17:19 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200228 06:56:26